Join
Live feed
·
INSIDERFilingvia Quantisnow
PDS Biotechnology Corporation logo

SEC Form 4: Hill Matthew C bought $27,860 worth of shares (3,100 units at $8.99), increasing direct ownership by 297% to 3,875 units

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PDSB (PDS Biotechnology Corporation) and more on Quantisnow.